PDL BioPharma
NASDAQ:PDLI
$6.49
$0.01
(0.08%)
Quote as of 4:00 PM EST on 02/09/12
|
$6.49
$0.01
(0.08%)
|
|
| Today's Open | $6.49 |
|---|---|
| Previous Close | $6.49 |
| Daily Range | $6.46 - $6.53 |
| 52-Week Range | $4.66 - $6.70 |
| Market Cap | $907.53M |
| P/E Ratio | 8.65 |
| Dividend (Yield) | $0.60 (9.3%) |
| Ex-Dividend Date Dividend Pay Date |
03/05/12 03/14/12 |
| Volume | 2,074,963 |
| Average Daily Volume | 2,320,356 |
| Current FY EPS | $1.14 |
PDLI Information
| Description |
|---|
| A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
1 Great Dividend to Buy, 1 Weak Dividend to Sell
Among 5 Small-Cap Dividend Dynamos, 1 Stands Out
US Stock Futures: HOT STOCKS TO WATCH
Biotech Royalties, Almost as Good as Cash
US Stock Futures: HOT STOCKS TO WATCH
Don't Get Trapped by High Dividends - Analyst Blog
Here's What 1 of the Best Investors Is Buying
Alexion Looks Fine With These 2 Metrics
Has PDL BioPharma Become the Perfect Stock?
The Highest-Rated Biotech Stocks
